Get in Touch With Us
Revenue Growth: Net revenue increased by 10.1% to 470 cr, up from 427 cr in Q3 FY25.
EBITDA Surge: EBITDA grew by 11.5% , reaching 193 cr in Q4 FY25, compared to 173 cr in Q4 FY24.
Profit after tax (PAT) : PAT surged 22% to 118 cr in Q4 FY25 up from 97 cr in Q4 FY24.
Expansion in medical devices : The medical device segment revenue grew by 13% YoY, reaching 123 cr. With over 14.2 million glucometers installed, production expansion is underway to meet growing demand.
Pharma Segment Growth: The pharma division saw a 8.5% revenue increase, with export revenue up by 5% bolstered by strong performance in Europe (up 50%) and Asia.
Revenue Growth: Net revenue increased by 4% to ₹442.71 crore, up from ₹425.00 crore in Q2 FY24
EBITDA Surge: EBITDA grew by 33%, reaching ₹49.06 crore in Q2 FY25, compared to ₹36.83 crore in Q2 FY24.
Profit After Tax (PAT): PAT surged 64% to ₹34.85 crore for Q2 FY25, up from ₹21.26 crore in the same quarter last year.
Expansion in Medical Devices: The medical devices segment revenue grew by 9.35% YoY, reaching ₹133 crore. With over 13 million glucometers installed, production expansion is underway to meet growing demand.
Pharma Segment Growth: The pharma division saw a 9% revenue increase, with export revenue up by 21%, bolstered by strong performance in Europe (up 60%) and Asia.
Strategic Investment for Future Growth: Morepen raised ₹200 crore via Qualified Institutional Placement (QIP), facilitating capacity expansions across API and medical devices.
Empowering Health. Everywhere
Morepen is dedicated to providing affordable, high-quality healthcare solutions through innovative pharmaceutical and medical technology products. We strive to make health accessible for all and achieve a global reach.
Excellence. Passion. Action. Innovation
Morepen is driven by a commitment to excellence in everything we do. Our three core values – Passion, Action, and Innovation – guide our actions. We prioritize delivering superior quality products, efficient distribution networks, and exceptional customer service. We are a passionate and results-oriented team, leveraging technology for continuous research and development. Our goal is to remain at the forefront of healthcare solutions.
.jpg)
Special window for re-lodgement of transfer requests of physical shares
Newspaper publication – Special window for re-lodgement of transfer requests of physical shares
Report for the month of July, 2025.
Report for the month of August, 2025.
Report for the month of September, 2025.
Report for the month of October, 2025.
Report for the month of November, 2025.
Report for the month of December, 2025.
Report for the period 1 January 2026 to 6 January 2026
Special window for transfer and dematerialisation of physical shares
Chief Financial Officer
Ajay Kumar Sharma
2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar
Sector -20, Gurugram, Haryana - 122016
0124-4892000
[email protected]
Annual Return
Annual Secretarial Compliance Report
Newspaper Advertisements
IT Policy
Sustainability
Certificates
Human Resources
